Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.88 USD | -0.88% | -4.33% | -6.84% |
Mar. 13 | Transcript : Bio-Techne Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:30 AM | |
Feb. 05 | North American Morning Briefing : Hopes of March -2- | DJ |
Chart calendar Bio-Techne Corporation
Upcoming events on Bio-Techne Corporation
Past events on Bio-Techne Corporation
2024-03-13 08:30 am | Barclays Global Healthcare Conference |
2024-02-08 | Ex-dividend day |
2024-02-04 | Genome Biology and Technology General Meeting |
2024-02-01 09:00 am | Q2 2024 Earnings Call |
2024-02-01 06:30 am | Q2 2024 Earnings Release |
2024-01-19 10:00 am | Phacilitate Advanced Therapies Conference |
2024-01-18 08:00 am | Phacilitate Advanced Therapies Conference - Roundtable Talk |
2024-01-10 12:00 pm | JPMorgan Healthcare Conference |
2023-11-29 02:10 pm | Evercore ISI HealthCONx Conference |
2023-11-15 03:00 pm | Stephens Investment Conference |
2023-11-15 02:00 pm | Association for Molecular Pathology Meeting |
2023-11-15 08:35 am | Stifel Healthcare Conference |
2023-11-08 | Ex-dividend day |
2023-11-04 07:00 pm | Society for Immunotherapy of Cancer Meeting - Poster number: 222D |
2023-11-04 11:55 am | Society for Immunotherapy of Cancer Meeting - Poster number: 222D |
2023-11-04 11:55 am | Society for Immunotherapy of Cancer Meeting - Poster number: 102 |
2023-11-03 05:10 pm | Society for Immunotherapy of Cancer Meeting - Poster number: 71 |
2023-11-03 05:10 pm | Society for Immunotherapy of Cancer Meeting - Poster number: 107 |
2023-11-03 05:10 pm | Society for Immunotherapy of Cancer Meeting - Poster number: 65 |
2023-11-03 05:10 pm | Society for Immunotherapy of Cancer Meeting - Poster number: 1475 |
Past dividends on Bio-Techne Corporation
2024-02-08 | Quarterly 0.08 USD |
2023-11-08 | Quarterly 0.08 USD |
2023-08-16 | Quarterly 0.08 USD |
2023-05-11 | Quarterly 0.08 USD |
2023-02-09 | Quarterly 0.08 USD |
2022-11-09 | Quarterly 0.32 USD |
2022-08-11 | Quarterly 0.32 USD |
2022-05-12 | Quarterly 0.32 USD |
2022-02-09 | Quarterly 0.32 USD |
2021-11-09 | Quarterly 0.32 USD |
Annual results
Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 714 722 -1.1% | 739 728 1.46% | 931 916 1.59% | 1 106 1 108 -0.24% | 1 137 1 143 -0.51% | 1 148 |
EBITDA Million USD | Released Forecast Spread | 264 280 -5.54% | 268 254 5.36% | 386 378 1.97% | 449 449 0.14% | 441 446 -1.04% | 401 |
EBIT Million USD | Released Forecast Spread | 245 248 -1.47% | 246 233 5.66% | 362 354 2.29% | 421 424 -0.67% | 410 412 -0.53% | 367 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 112 130 -13.57% | 276 230 19.97% | 148 200 -25.75% | 301 294 2.64% | 339 331 2.36% | 200 |
Net income Million USD | Released Forecast Spread | 96,1 110 -12.32% | 229 181 26.37% | 140 169 -17.15% | 272 270 0.74% | 285 274 4.06% | 177 |
EPS USD | Released Forecast Spread | 0,62 0,71 -12.41% | 1,46 1,15 26.58% | 0,87 1,05 -17.26% | 1,66 1,64 1.22% | 1,76 1,69 4.05% | 1,10 |
Announcement Date | 06/08/19 | 04/08/20 | 05/08/21 | 04/08/22 | 08/08/23 | - |
Quarterly results
Fiscal Period | Juni | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 269 267 1.01% | 290 279 3.98% | 288 287 0.41% | 270 282 -4.29% | 272 290 -6.26% | 294 299 -1.48% | 301 308 -2.26% | 277 288 -3.72% | 273 278 -1.85% | 293 | 306 | 293 | 298 | 321 |
EBITDA Million USD | Released Forecast Spread | 110 104 5.21% | 122 116 4.59% | 114 113 1.34% | 101 102 -1.04% | 104 109 -4.49% | 116 117 -0.9% | 120 122 -1.32% | 95,6 99,1 -3.51% | 93,2 98,1 -4.92% | 103 | 112 | 103 | 105 | 119 |
EBIT Million USD | Released Forecast Spread | 103 97,1 5.87% | 115 107 6.79% | 107 111 -3.64% | 93,2 97,5 -4.47% | 96,5 103 -5.98% | 109 110 -1.33% | 112 114 -1.51% | 86,9 91,9 -5.41% | 81,9 87,2 -6.03% | 94,2 | 103 | 95,4 | 98,1 | 110 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 86,2 61,6 39.87% | 68,8 72,5 -5.1% | 79,1 77,2 2.4% | 104 64,4 61.11% | 66,4 73,9 -10.12% | 80,2 77,2 3.92% | 88,3 80,5 9.71% | 49,6 61,1 -18.87% | 33,4 53,7 -37.86% | 54,1 | 62,9 | 57,1 | 63,7 | 70,9 |
Net income Million USD | Released Forecast Spread | 80,2 49,8 60.89% | 60,7 57,6 5.4% | 61,5 62,6 -1.79% | 89,6 52,8 69.62% | 50,0 55,4 -9.73% | 70,2 63,1 11.3% | 75,5 64,0 17.92% | 51,0 47,1 8.25% | 27,5 43,3 -36.5% | 45,4 | 53,3 | 46,8 | 52,1 | 58,9 |
EPS USD | Released Forecast Spread | 0,49 0,30 60.55% | 0,37 0,35 5.97% | 0,38 0,38 -0.66% | 0,55 0,32 70.22% | 0,31 0,34 -9.05% | 0,43 0,39 10.26% | 0,47 0,40 18.49% | 0,31 0,29 6.28% | 0,17 0,27 -35.85% | 0,28 | 0,33 | 0,29 | 0,33 | 0,37 |
Announcement Date | 01/02/22 | 04/05/22 | 04/08/22 | 01/11/22 | 02/02/23 | 03/05/23 | 08/08/23 | 31/10/23 | 01/02/24 | - | - | - | - | - |
2024-03-19 | OMNIAB, INC.: Q4 2023 Earnings Release |
2024-03-19 | ALVOTECH: Q4 2023 Earnings Release |
2024-03-20 01:00 am | VALNEVA: Q4 2023 Earnings Release |
2024-03-20 | ARS PHARMACEUTICALS, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-20 | MINERALYS THERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-03-20 | VERA THERAPEUTICS, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-20 | EXSCIENTIA PLC: Q4 2023 Earnings Release |
2024-03-22 | VORONOI, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-24 | TANGO THERAPEUTICS, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-24 | FRONTAGE HOLDINGS CORPORATION: Q4 2023 Earnings Release (Projected) |
Past sector events for Bio-Techne Corporation
2024-03-14 | HILLEVAX, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-14 07:00 am | CULLINAN ONCOLOGY, INC.: Q4 2023 Earnings Release |
2024-03-13 04:01 pm | MORPHOSYS AG: Q4 2023 Earnings Release |
2024-03-12 | VIRIDIAN THERAPEUTICS, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-11 09:27 pm | BELITE BIO, INC: Q4 2023 Earnings Release |
2024-03-11 05:16 pm | ENGENE HOLDINGS INC.: Q1 2024 Earnings Release |
2024-03-11 04:03 pm | OLEMA PHARMACEUTICALS, INC.: Q4 2023 Earnings Release |
2024-03-11 06:30 am | FORTREA HOLDINGS INC.: Q4 2023 Earnings Release |
2024-03-09 | GENSCRIPT BIOTECH CORPORATION: Q4 2023 Earnings Release |
2024-03-08 04:01 pm | JANUX THERAPEUTICS, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Bio-Techne Corporation - Nasdaq
- Calendar Bio-Techne Corporation